Tarbox Family Office’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-92
| Closed | -$45K | – | 385 |
|
|
2022
Q1 | $45K | Sell |
92
-19
| -17% | -$8.69K | 0.01% | 190 |
|
|
2021
Q4 | $51K | Hold |
111
| – | – | 0.01% | 220 |
|
|
2021
Q3 | $41K | Sell |
111
-3
| -3% | -$1.14K | 0.01% | 264 |
|
|
2021
Q2 | $44K | Hold |
114
| – | – | 0.01% | 256 |
|
|
2021
Q1 | $41K | Hold |
114
| – | – | 0.01% | 215 |
|
|
2020
Q4 | $37K | Buy |
114
+6
| +6% | +$1.84K | 0.01% | 222 |
|
|
2020
Q3 | $29K | Sell |
108
-73
| -40% | -$19.6K | 0.01% | 236 |
|
|
2020
Q2 | $48K | Buy |
181
+79
| +77% | +$21.1K | 0.01% | 184 |
|
|
2020
Q1 | $23K | Buy |
102
+16
| +19% | +$4.36K | 0.01% | 232 |
|
|
2019
Q4 | $26K | Sell |
86
-4
| -4% | -$1.1K | 0.01% | 249 |
|
|
2019
Q3 | $22K | Hold |
90
| – | – | 0.01% | 242 |
|
|
2019
Q2 | $25K | Buy |
90
+16
| +22% | +$4.37K | 0.01% | 223 |
|
|
2019
Q1 | $21K | Hold |
74
| – | – | 0.01% | 225 |
|
|
2018
Q4 | $19K | Sell |
74
-9
| -11% | -$2.48K | 0.01% | 224 |
|
|
2018
Q3 | $23K | Hold |
83
| – | – | 0.01% | 229 |
|
|
2018
Q2 | $20K | Hold |
83
| – | – | 0.01% | 230 |
|
|
2018
Q1 | $18K | Buy |
83
+9
| +12% | +$2.11K | 0.01% | 256 |
|
|
2017
Q4 | $17K | Hold |
74
| – | – | 0.01% | 252 |
|
|
2017
Q3 | $14K | Buy |
74
+11
| +17% | +$2.09K | 0.01% | 267 |
|
|
2017
Q2 | $12K | Hold |
63
| – | – | 0.01% | 269 |
|
|
2017
Q1 | $10K | Hold |
63
| – | – | 0.01% | 291 |
|
|
2016
Q4 | $9K | Sell |
63
-15
| -19% | -$2.01K | 0.01% | 261 |
|
|
2016
Q3 | $10K | Buy |
78
+3
| +4% | +$387 | 0.01% | 252 |
|
|
2016
Q2 | $10K | Buy |
75
+17
| +29% | +$2.33K | 0.01% | 243 |
|
|
2016
Q1 | $8K | Sell |
58
-22
| -28% | -$2.94K | 0.01% | 271 |
|
|
2015
Q4 | $11K | Sell |
80
-21
| -21% | -$2.89K | 0.01% | 216 |
|
|
2015
Q3 | $14K | Buy |
101
+4
| +4% | +$601 | 0.01% | 191 |
|
|
2015
Q2 | $16K | Hold |
97
| – | – | 0.01% | 176 |
|
|
2015
Q1 | $15K | Hold |
97
| – | – | 0.01% | 190 |
|
|
2014
Q4 | $12K | Sell |
97
-1
| -1% | -$124 | 0.01% | 216 |
|
|
2014
Q3 | $12K | Buy |
98
+3
| +3% | +$344 | 0.01% | 210 |
|
|
2014
Q2 | $10K | Hold |
95
| – | – | 0.01% | 224 |
|
|
2014
Q1 | $9K | Sell |
95
-521
| -85% | -$47.1K | 0.01% | 255 |
|
|
2013
Q4 | $57K | Buy |
+616
| New | +$54.7K | 0.05% | 124 |
|
Other funds holding ELV
Tarbox Family Office's ELV Position: Q2 2022 in Review
Tarbox Family Office sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 92 shares — an estimated $45K sold.
Tarbox Family Office first reported a position in ELV in Q4 2013 and held it in 34 quarters. The position peaked at $57K in Q4 2013. 1,442 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Tarbox Family Office reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
- Tarbox Family Office sold 92 Elevance Health shares in Q2 2022, an estimated $45K.
- Tarbox Family Office first reported a position in Elevance Health in Q4 2013 and held it in 34 quarters.
- Tarbox Family Office's Elevance Health position peaked at $57K in Q4 2013.
- 1,442 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.